Introduction
Listing venue choice is one of the principal strategic decisions in any IPO process. Issuers and ECM bankers weigh float requirements, listing standards, investor base, fees, sector orientation, and index access across the major venues: NYSE, Nasdaq (the technology and biotech leader), HKEX (the hub for Mainland China and Asian issuers), and London's LSE. In the first nine months of 2026, Nasdaq ranked first globally by IPO funds raised and Hong Kong second, per KPMG's third-quarter 2026 IPO market review. This article covers each venue's standards, fees, and issuer fit, then the framework bankers use to choose.
- Listing Venue
The primary stock exchange where a company lists its shares for public trading. Beyond the four headline venues, regional exchanges such as Euronext, SGX, ASX and TSX compete for mandates. The choice shapes post-IPO trading, compliance burden, investor demand, and index eligibility.
NYSE: The World's Largest Exchange
The New York Stock Exchange anchors the global listing universe with the highest combined market capitalization of any exchange.
Listing Standards
Under NYSE's initial listing standards, an IPO needs at least $40 million in market value of publicly held shares ($100 million for non-IPO listings), 400 round-lot holders, and a $4.00 price, plus either the earnings test ($10 million of adjusted pre-tax income over three years) or a $200 million global market capitalization. The initial listing fee is a flat $325,000.
Issuer Profile Fit
NYSE captures large traditional-industry issuers (financials, industrials, consumer products), foreign large-caps, and selected technology IPOs such as Klarna and Figma in 2025. Its premium positioning supports brand and credibility, particularly for non-tech issuers.
Recent Changes
Since April 2025, new NYSE listings pay only the initial fee and their primary-class annual fee for five years (a five-year fee concession), and since May 2025 non-North American IPO issuers may count worldwide shareholders toward the round-lot test.
Nasdaq: Technology and Biotech Leadership
Nasdaq's structural focus on technology and biotech has made it the dominant US listing venue by deal count.
Listing Standards
Nasdaq's three tiers, per its Initial Listing Guide, turn mainly on the market value of unrestricted publicly held shares (MVUPHS). An IPO needs $45 million on the Global Select Market (plus an earnings, cash-flow, revenue, or assets test), $15 million to $20 million on the Global Market, and $15 million on the Capital Market, raised from the offering itself on the two lower tiers. Under rules the SEC approved in May 2026, a company principally operating in China must also raise at least $25 million in a US firm-commitment IPO.
Listing Fees
Global Select and Global Market entry fees are a flat $325,000 (including a $25,000 application fee), level with NYSE. The Capital Market charges $50,000 or $75,000 depending on shares outstanding, so Nasdaq's entry-cost edge sits in the small-cap tier.
Listings Leadership in 2025 and 2026
In 2025, 81 percent of new US IPOs chose Nasdaq, led by Medline and CoreWeave. In 2026 the count lead became a dollar lead: KPMG ranks Nasdaq first globally by IPO funds raised in the first nine months, with SpaceX and SK hynix alone raising US$112.8 billion, nearly 40 percent of global IPO proceeds.
HKEX: The Hub for Mainland China and Asian Issuers
HKEX ranked first globally in 2025 (about US$36 billion raised) and second behind Nasdaq in the first nine months of 2026, with 116 listings raising over HK$388 billion, a record run explained in how A+H listings work.
Listing Standards (Post-August 2025 Reforms)
Since August 2025, HKEX's tiered public float steps down with size, from 25 percent for issuers worth up to HK$6 billion to the greater of 10 percent or HK$4.5 billion above HK$30 billion. A separate free float test requires 10 percent of the class worth at least HK$50 million, or HK$600 million of unrestricted shares; A+H issuers need H shares equal to 10 percent of the class or worth HK$3 billion. At least 40 percent of the offer goes to the bookbuilding tranche.
Issuer Profile Fit
HKEX is the principal venue for Mainland China A-share dual listings (A+H), Asian regional issuers, and companies seeking Stock Connect Southbound flows. The 2025-2026 surge came largely from A-share companies using the fast-track channel for issuers worth at least HK$10 billion.
Cornerstone Framework
HKEX's cornerstone framework (standard 6-month lockup retained in August 2025, after a staggered approach was consulted on but not adopted) is a distinctive structural feature. The 40 percent bookbuilding floor effectively caps cornerstone allocations, and the framework supported the 2025 cornerstone resurgence (BlackRock, Temasek, QIA, Mubadala, Fidelity all reanchored).
LSE: The UK Reform Beneficiary
The London Stock Exchange operates under the UK Listing Rules that took effect in July 2024.
Listing Standards (Post-2024 Reforms)
The new rules consolidated the previous premium and standard segments into a single listing category. They kept the 10 percent free float (cut from 25 percent in December 2021) and the £30 million minimum market capitalization set at the same time. Dual-class structures became far more flexible: no time limit for founders and directors, and a 10-year max for pre-IPO institutional holders.
Issuer Profile Fit
LSE captures UK-domiciled growth companies, European mid-caps, mining and natural resources (a historic strength), and certain emerging-markets issuers. The 2024 reforms improved its position for selected technology and growth mandates.
Recent Activity
UK 2025 produced 23 IPOs raising £1.9 billion (highest since 2021), with Q4 strongest (Shawbrook £348M, Princes Group £400M). The table compares the four venues, with KPMG's 2026 ranking by IPO funds raised.
| Venue | Float / Size Minimum (IPO) | Initial Listing Fee | Sector Orientation | First Nine Months 2026 (KPMG rank) |
|---|---|---|---|---|
| NYSE | $40M public float value | $325K | Large-cap traditional, financials, mega-IPOs | #4 (New York) |
| Nasdaq | $15M-$45M unrestricted float, by tier | $50K-$325K by tier | Technology, biotech, growth | #1 |
| HKEX | 25% to 10% public float; 10% free float | Varies | A+H dual listings, Asian regionals | #2; HK$388B+ |
| LSE | 10% free float / £30M market cap | Standard fee structure | UK growth, European mid-cap, resources | Outside top five |
Strategic Decision Framework
Bankers weigh venue choice across several dimensions, best seen through one issuer's real alternatives.
Capital Pool Targeting
The principal consideration is investor base. NYSE/Nasdaq provide the deepest US institutional and retail capital. HKEX provides Asian institutional capital plus Stock Connect Southbound flows. LSE provides UK and European institutional capital.
Sector Match
Each venue has settled sector orientations (Nasdaq in technology and biotech, NYSE in traditional industries, HKEX in Asian and Mainland China issuers, LSE in UK growth and natural resources), and issuers in a venue's core sectors get deeper analyst coverage and dedicated investor pools.
Regulatory Burden
US listings impose the heaviest ongoing SEC reporting. HKEX listings require Hong Kong reporting plus CSRC filing for A+H structures. LSE's post-2024 framework is simpler but still requires UK reporting.
Public Float vs Free Float
Listing standards and index inclusion use two related concepts. Public float (the US-exchange definition) is shares outstanding less those held by officers, directors, and 10 percent or greater holders; Nasdaq counts only unrestricted shares, excluding anything under resale restrictions, lockups included. Free float, used by index providers, is narrower: it also strips out strategic holders, government stakes, employee plans, and cross-shareholdings. Russell weights constituents by float-adjusted market cap; S&P uses an investable-weight factor that excludes the same categories. The distinction matters because a company can clear a venue's public-float threshold while having a much smaller free float that limits its index weight and passive-bid demand.
Lockup Considerations
NYSE and Nasdaq do not require mandatory cornerstone lockups. HKEX's 10 percent free float plus 6-month cornerstone lockup creates structural anchor support. Cornerstone-anchored execution typically favors HKEX; market-driven post-IPO trading favors US venues.
How 2026's Largest Deals Chose Their Venues
Nasdaq won the two largest listings of 2026, for different reasons.
SpaceX and the Nasdaq-100 Fast-Entry Rule
SpaceX listed on Nasdaq (ticker SPCX) in June 2026 with an index route no other exchange could offer. Under the fast-entry rule effective May 1, 2026, a new listing ranking in the index's top 40 can join the Nasdaq-100 after 15 trading days instead of three months, and only Nasdaq-listed companies qualify, per Nasdaq's fast-entry FAQ. SpaceX joined on July 7, bringing passive-fund buying within a month of its record IPO.
SK hynix: A Secondary ADR on Nasdaq
SK hynix priced Nasdaq ADRs at $149 in July 2026, raising about $26.5 billion. Already listed in Seoul, it is a secondary listing, and Nasdaq ranks a non-primary ADR on its US depositary shares alone, so the index pull is weaker. The aims were wider global investor access and a narrower valuation gap with Micron, a classic ADR rationale.
Hong Kong and London
Hong Kong's second place rests on the A+H wave, which KPMG credits with nearly 70 percent of its 2026 proceeds. London was thin: EY-Parthenon counts eight UK listings raising £606.9 million in the first nine months, proof that listing reform alone does not create a pipeline.
Regional Venues: SGX, TSX, ASX
SGX wins REITs and Southeast Asian issuers (NTT DC REIT's US$773 million IPO in July 2025 was its largest REIT listing in over a decade), while TSX and ASX capture resources, mining, and selected technology mandates.
The listing venue choice framework completes Section 7. The next section turns to careers and interviewing for ECM, translating this market context into practical career navigation.
